University of Texas's MD Anderson Cancer Center Research Highlights for July 27
July 28, 2022
July 28, 2022
HOUSTON, Texas, July 28 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Featuring targeted therapies for BPDCN and AML, insights to improve immunotherapy in pancreatic cancer, and surgical advances for metastatic cancers
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research f . . .
* * *
Featuring targeted therapies for BPDCN and AML, insights to improve immunotherapy in pancreatic cancer, and surgical advances for metastatic cancers
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research f . . .